Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic patients.
Wasada
T
T
Kawahara
R
R
Iwamoto
Y
Y
D000005:Abdomen; D000273:Adipose Tissue / Q000187:drug effects*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D001971:Bromocriptine / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000097:blood / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology*; D018491:Dopamine Agonists / Q000494:pharmacology*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D009765:Obesity; D011388:Prolactin / Q000097:blood; D012867:Skin
D001786:Blood Glucose; D018491:Dopamine Agonists; D001971:Bromocriptine; D011388:Prolactin